spacer
home > ebr > winter 2001 > the biopharmaceutical sector in the south east of england
PUBLICATIONS
European Biopharmaceutical Review

The Biopharmaceutical Sector in the South East of England

The South East Region, which includes Oxford, has the largest representation of pharmaceutical and bioscience companies in the UK and represents one of the most significant clusters globally.

The Fact

The top 12 pharma companies in the world are located in the South East, and these are:

Merck,Bristol-Myers Squibb,Johnson and Johnson,Novartis,Pfizer,GSK,Abbott,Roche group,Aventis,Lilly,American Home Products

Many of these companies have large-scale research and development (R&D) projects in the region, such as Pfizer's global R&D campus at Sandwich in Kent, where four of their top 10 products were discovered. This, alongside the expansion of Lilly's R&D facility in Surrey, represents major investment in the region.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Peter Read CBE, Chairman of the Business Development

Committee and Board Member of SEEDA Dr Peter Read CBE is the former Chairman of Hoechst Group of Companies in the UK, including pharmaceuticals, chemicals and agriculture. He is a past President of the Association of the British Pharmaceutical Industry, a Board Member of SEEDA and Chairman of the Business Development Committee.

spacer
Dr Peter Read
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

DSV and Ørsted to Test Cargo Drones at Anholt Offshore Wind Farm

DSV, the global Danish transport and logistics company, and Ørsted, the world-leading Danish energy company, will test long-distance drone transport of spare parts and tools in the Kattegat Sea in Denmark.
More info >>

White Papers

BioT ULT Transporter

BioCision

The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement